Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07130162

Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

The present study aims to evaluate the serum level of PIGU protein in patients with breast cancer and its relation with clinical, laboratory and pathological data of the patients.

Official title: Detection of Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein as Serum Biomarker for Breast Cancer

Key Details

Gender

FEMALE

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

96

Start Date

2025-09-01

Completion Date

2026-10

Last Updated

2025-08-19

Healthy Volunteers

Not specified

Conditions

Interventions

DIAGNOSTIC_TEST

Measurement of serum PIGU protein concentrations of patients and controls by Enzyme-Linked Immunosorbent Assay (ELISA)

Measurement of serum PIGU protein concentrations of patients and controls by Enzyme-Linked Immunosorbent Assay (ELISA)